CARDIO DIAGNOSTICS HOLDINGS, INC. (CDIO)
Stock research & financials
Reported business results for SEC issuer CIK 0001870144. These figures are automatically extracted and have not received the manual review applied to our 22 reviewed profiles.
The annual figures, at a glance.
Annual period ended 2025-12-31. These are historical business results, not current prices or forecasts.
Net profit / loss
-6.5mUSDProfit after expenses; a negative figure is a loss.Original filing ↗Operating cash flow
-5.73mUSDCash generated or used by business operations.Original filing ↗Debt
UnavailableNot verified in this snapshot. Check the balance sheet in the original filing.Unavailable does not mean zero. Rounded figures are for scanning; detailed values and source dates follow below.
Inspect reported figures
Choose a measure, check the periods and follow the filing. This uses the same historical snapshot as the figures above.
Revenue
Reported unit: USD. Amounts below are not share prices.
Bars show absolute magnitude. Negative amounts keep their minus sign; zero has no bar.
| Period | Period dates | Amount |
|---|---|---|
| 2025-12-31 | 2025-01-01 to 2025-12-31 | 14,825 |
One period is available here. No change or trend has been inferred.
Open the original filing for this evidence →
Check the filing for restatements, accounting definitions and newer reports. These figures alone do not establish whether a stock is suitable.
Sector & issuer classification
Reported industry: In Vitro & In Vivo Diagnostic Substances (SIC 2835). Sector evidence ↗ · checked 2026-11-10. Official SEC SIC mapped to editorial discovery group. A sector is a discovery group, not a security-type or current trading-status verification.
Explore the chart and market statistics
Dividend yield & key stats
Loading statistics for CDIO…
- Dividend yield
- Unavailable until provider data loads
- Market cap
- Unavailable until provider data loads
- P/E ratio
- Unavailable until provider data loads
- Earnings per share
- Unavailable until provider data loads
Missing data does not mean zero. Coverage varies by listing.
Sources, dates and coverage
Snapshot checked 2026-10-17. This is dated annual data, not a live price, forecast, valuation or confirmation of the latest filing. An issuer may have several listed securities; these are company figures, not separate financial statements for each listing.
Reporting periods and units appear with each figure. Missing measures remain unavailable. Filing dates are shown where supplied by the source; otherwise check the original filing before relying on it.
Check the issuer’s SEC filings ↗CARDIO DIAGNOSTICS HOLDINGS, INC.: annual results at a glance
The most recent retained annual period ended 2025-12-31. 4 financial measures are available in this snapshot. Figures below describe the business; they are not a share price.
Changes between retained annual periods
Periods of similar length and matching units only. Restatements, acquisitions and accounting changes can affect comparisons; read the filings for context.
Revenue
2024-12-31 → 2025-12-31
34,890 → 14,825 USD
-57.51% change
Bar lengths show magnitude; signed values are labelled above.Check the underlying filing ↗Net income / loss
2024-12-31 → 2025-12-31
-8,383,453 → -6,498,167 USD
Percentage change is not shown when the earlier value is zero or negative.
Bar lengths show magnitude; signed values are labelled above.Check the underlying filing ↗Operating cash flow
2024-12-31 → 2025-12-31
-4,993,104 → -5,726,833 USD
Percentage change is not shown when the earlier value is zero or negative.
Bar lengths show magnitude; signed values are labelled above.Check the underlying filing ↗Diluted earnings per share
2024-12-31 → 2025-12-31
-9.35 → -3.71 USD/shares
Percentage change is not shown when the earlier value is zero or negative.
Bar lengths show magnitude; signed values are labelled above.Check the underlying filing ↗CDIO stock research: questions answered
Use these dated financial results as a starting point, then check the original reports for context.
What was CARDIO DIAGNOSTICS HOLDINGS, INC.'s reported revenue?
For the annual period ended 2025-12-31, CARDIO DIAGNOSTICS HOLDINGS, INC. reported revenue of 14,825 USD. This is a historical reported result, not a forecast.
Read the original filing for this figure ↗What was CARDIO DIAGNOSTICS HOLDINGS, INC.'s reported net income?
For the annual period ended 2025-12-31, CARDIO DIAGNOSTICS HOLDINGS, INC. reported net income of -6,498,167 USD. This is a historical reported result, not a forecast.
Read the original filing for this figure ↗What was CARDIO DIAGNOSTICS HOLDINGS, INC.'s reported operating cash flow?
For the annual period ended 2025-12-31, CARDIO DIAGNOSTICS HOLDINGS, INC. reported operating cash flow of -5,726,833 USD. This is a historical reported result, not a forecast.
Read the original filing for this figure ↗What was CARDIO DIAGNOSTICS HOLDINGS, INC.'s reported diluted earnings per share?
For the annual period ended 2025-12-31, CARDIO DIAGNOSTICS HOLDINGS, INC. reported diluted earnings per share of -3.71 USD/shares. This is a historical reported result, not a forecast.
Read the original filing for this figure ↗Does this page show CDIO's live share price?
No. This page covers historical company financial results. It does not provide a live share price, current valuation or buy/sell recommendation.
Find CARDIO DIAGNOSTICS HOLDINGS, INC.'s SEC filings and check for newer reports ↗
Understand the figures before comparing stocks
Sources, checks and calculation methods →
Revenue, profit and cash flow explained →
Annual period ended 2025-12-31
2025-01-01 – 2025-12-31 · Reporting currency USD · filing date: check original source
Revenue
14,825USD
Original filing for this figure ↗Net income / loss
-6,498,167USD
Original filing for this figure ↗Operating cash flow
-5,726,833USD
Original filing for this figure ↗Diluted earnings per share
-3.71USD/shares
Original filing for this figure ↗Annual period ended 2024-12-31
2024-01-01 – 2024-12-31 · Reporting currency USD · filing date: check original source
Revenue
34,890USD
Original filing for this figure ↗Net income / loss
-8,383,453USD
Original filing for this figure ↗Operating cash flow
-4,993,104USD
Original filing for this figure ↗Diluted earnings per share
-9.35USD/shares
Original filing for this figure ↗Annual period ended 2023-12-31
2023-01-01 – 2023-12-31 · Reporting currency USD · filing date: check original source
Revenue
17,065USD
Original filing for this figure ↗Net income / loss
-8,376,834USD
Original filing for this figure ↗Operating cash flow
-5,672,175USD
Original filing for this figure ↗Diluted earnings per share
-0.66USD/shares
Original filing for this figure ↗Continue your research
Check the original reports, investigate debt, cash flow and dilution, and use the workspace to save your own notes.
